A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone as First-line Treatment in Subjects With Locally Recurrent or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Linifanib (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 20 Jun 2012 Additional trial locations (Czech Republic, Netherlands, United Kingdom) added as reported by European Clinical Trials Database.
- 26 Mar 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.